|
US2011196040A1
|
|
Skin Penetration Enhancing Systems for Polar Drugs
|
|
EP2313366A2
|
|
Processes for the preparation of 2,5-dihydroxybenzenesulfonic acid salts
|
|
WO2008113863A2
|
|
Nitrosated derivatives of 2,5-dihydroxybenzene compounds
|
|
WO2008020030A1
|
|
2,5-dihydroxybenzene compounds for the treatment of psoriasis
|
|
WO2008020026A1
|
|
Use of 2,5-dihydroxybenzene derivatives for treating dermatitis
|
|
EP2056805A1
|
|
Use of 2, 5-dihydroxybenzene derivatives for the treatment of tissue reactive diseases
|
|
US2007149618A1
|
|
Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer, rosacea and psoriasis
|
|
ES2315119A1
|
|
USE OF DERIVATIVES 2,5-HYDROXIBENCENICOS IN THE MANUFACTURE OF MEDICINES AND COSMETICS.
|
|
ES2315118A1
|
|
USE OF 2,5-DIHYDROXIBENCENIC COMPOUNDS AND DERIVATIVES IN THE PREPARATION OF USEFUL MEDICINES IN THE TREATMENT OF ROSACEA AND PSORIASIS.
|
|
ES2315117A1
|
|
USE OF 2,5-DIHYDROXIBENCENIC DERIVATIVES IN THE PREPARATION OF USEFUL MEDICATIONS IN THE TREATMENT OF ASTHMA.
|
|
US2008293816A1
|
|
Use of 2,5-dihydroxybenzenesulphonic acid in the production of medicaments for the treatment of angiodependent diseases such as cancer and psoriasis
|
